BET-IN-25
Product Specifications
UNSPSC Description
BET-IN-25 (compound 7) is an oral bioactive inhibitor of bromodomain (BD1) and BD2, with the IC50s of 0.18 μM and 9.2 μM, respectively[1].
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bet-in-25.html
Smiles
CN1C=C(C2=NN(C)C=C2)C(OC(CN3CCN(S(=O)(C)=O)C[C@H]3C)=C4)=C4C1=O
Molecular Weight
419.50
References & Citations
[1]Shuichi Hagihara, et al. Discovery of a potent, orally available furopyridine derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor. Bioorg Med Chem Lett. 2024 Sep 1:109:129848.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162621/BET-IN-25-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162621/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal HNF-3 beta/FoxA2 Antibody (OTI3C10) [PE/Cy7]](https://cdn.genprice.uk/genprice/genprice5.png)
NBP2-70904PECY7 0.1 mL
Mouse Monoclonal HNF-3 beta/FoxA2 Antibody (OTI3C10) [PE/Cy7]
Ask
View Details 
